RANKINGS

Highest Gross Margin — Materials

Gross margin measures the percentage of revenue retained after cost of goods sold.

161 companies with Gross Margin data.

Ranked by Gross Margin(161)

#	Ticker	Name	Industry	Market Cap	Gross Margin
1	GPRE	GREEN PLAINS INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$1.0B	167.1%
2	NKTR	Nektar Therapeutics FY · 2025-12-31 Analysis WACC DCF	Other	$1.4B	100.0%
3	MGNX	MACROGENICS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$237M	100.0%
4	ABVC	ABVC BioPharma, Inc. FY · 2024-12-31 Analysis WACC DCF	Other	$26M	99.9%
5	LXRX	LEXICON PHARMACEUTICALS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$734M	99.4%
6	AGEN	AGENUS INC FY · 2025-12-31 Analysis WACC DCF	Other	$336M	99.1%
7	CORT	CORCEPT THERAPEUTICS INC TTM · 2026-06-30 Analysis WACC DCF	Other	$13.1B	98.3%
8	IONS	IONIS PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$7.3B	98.2%
9	NBIX	NEUROCRINE BIOSCIENCES, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$14.4B	98.0%
10	BCRX	BIOCRYST PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$2.1B	97.8%
11	EXEL	Exelixis Inc TTM · 2026-07-03 Analysis WACC DCF	Other	$14.8B	96.5%
12	GYRE	Gyre Therapeutics, Inc. FY · 2025-12-31 Analysis WACC DCF	Other	$728M	95.4%
13	RIGL	RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$912M	91.4%
14	ACAD	ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$3.3B	91.1%
15	MNKD	MannKind Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$1.0B	89.8%
16	CLDX	Celldex Therapeutics, Inc. FY · 2025-12-31 Analysis WACC DCF	Other	$2.3B	87.1%
17	CDXS	Codexis, Inc. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$154M	87.0%
18	VRTX	VERTEX PHARMACEUTICALS INC / MA FY · 2025-12-31 Analysis WACC DCF	Other	$128.5B	86.2%
19	UTHR	United Therapeutics Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$23.6B	86.1%
20	CPIX	Cumberland Pharmaceuticals Inc. FY · 2025-12-31 Analysis WACC DCF	Other	$105M	85.0%
21	ERNA	Ernexa Therapeutics Inc. FY · 2024-12-31 Analysis WACC DCF	Other	$3M	83.5%
22	INSM	INSMED INC TTM · 2026-06-30 Analysis WACC DCF	Other	$21.5B	83.5%
23	LLY	ELI LILLY AND COMPANY FY · 2025-12-31 Analysis WACC DCF	Other	$1.1T	83.0%
24	HALO	HALOZYME THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$12.6B	82.4%
25	TGTX	TG THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$8.5B	82.4%
26	ALNY	ALNYLAM PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$30.4B	79.8%
27	GILD	GILEAD SCIENCES, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$186.5B	79.6%
28	NVAX	NOVAVAX, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$2.1B	78.6%
29	LFVN	LIFEVANTAGE CORP FY · 2026-06-30 Analysis WACC DCF	Other	$75M	77.6%
30	USNA	USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 Analysis WACC DCF	Other	$276M	77.4%
31	BMRN	BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 Analysis WACC DCF	Other	$10.7B	76.1%
32	EL	Estee Lauder Companies Inc FY · 2026-06-30 Analysis WACC DCF	Other	$36.2B	75.5%
33	BIIB	BIOGEN INC. TTM · 2026-03-31 Analysis WACC DCF	Other	$33.9B	75.5%
34	MTEX	MANNATECH INC FY · 2025-12-31 Analysis WACC DCF	Other	$15M	74.9%
35	INVA	INNOVIVA, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$1.5B	74.8%
36	VCEL	VERICEL CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$2.1B	74.4%
37	ABEO	ABEONA THERAPEUTICS INC. FY · 2025-12-31 Analysis WACC DCF	Other	$280M	73.7%
38	HRTX	HERON THERAPEUTICS, INC. /DE/ FY · 2025-12-31 Analysis WACC DCF	Other	$79M	73.3%
39	PFE	PFIZER INC TTM · 2026-06-28 Analysis WACC DCF	Other	$161.9B	73.2%
40	NATR	NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$224M	73.2%
41	MRK	Merck & Co., Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$358.9B	73.0%
42	ZTS	Zoetis Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$31.3B	71.5%
43	BMY	BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$117.6B	70.2%
44	AMGN	Amgen Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$225.8B	69.5%
45	PLX	PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$224M	69.2%
46	MYGN	MYRIAD GENETICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$402M	68.8%
47	JNJ	Johnson & Johnson FY · 2025-12-28 Analysis WACC DCF	Other	$635.6B	67.9%
48	CELZ	Creative Medical Technology Holdings, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$6M	66.9%
49	TECH	BIO-TECHNE Corp FY · 2026-06-30 Analysis WACC DCF	Other	$11.4B	65.8%
50	IPAR	INTERPARFUMS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$3.6B	63.8%
51	COTY	COTY INC. FY · 2026-06-30 Analysis WACC DCF	Other	$2.6B	62.9%
52	IDXX	IDEXX LABORATORIES INC /DE TTM · 2026-06-30 Analysis WACC DCF	Other	$41.3B	62.4%
53	CL	COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$71.7B	60.4%
54	ANIP	ANI PHARMACEUTICALS, INC TTM · 2026-06-30 Analysis WACC DCF	Other	$1.7B	60.4%
55	KVUE	Kenvue Inc. TTM · 2026-06-28 Analysis WACC DCF	Other	$34.2B	58.2%
56	AMRN	AMARIN CORP PLC\UK FY · 2025-12-31 Analysis WACC DCF	Other	$244M	56.6%
57	ABT	ABBOTT LABORATORIES TTM · 2026-03-31 Analysis WACC DCF	Other	$176.2B	56.3%
58	WDFC	WD-40 COMPANY TTM · 2026-05-31 Analysis WACC DCF	Chemicals	$2.7B	55.8%
59	PRM	PERIMETER SOLUTIONS, INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$4.4B	54.7%
60	SIGA	Siga Technologies INC TTM · 2026-06-30 Analysis WACC DCF	Other	$227M	54.4%
61	RGEN	REPLIGEN CORP TTM · 2026-06-30 Analysis WACC DCF	Other	$11.0B	53.8%
62	TOMZ	TOMI ENVIRONMENTAL SOLUTIONS, INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$12M	52.9%
63	TEVA	TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 Analysis WACC DCF	Other	$48.0B	51.8%
64	GEVO	GEVO, INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$316M	51.2%
65	PG	PROCTER & GAMBLE CO FY · 2026-06-30 Analysis WACC DCF	Other	$355.8B	50.2%
66	LAB	Standard BioTools Inc. FY · 2025-12-31 Analysis WACC DCF	Other	$258M	49.9%
67	CSBR	CHAMPIONS ONCOLOGY, INC. TTM · 2026-07-31 Analysis WACC DCF	Other	$69M	49.8%
68	LIN	Linde plc TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$224.7B	48.3%
69	CYRX	CRYOPORT, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$853M	47.1%
70	NEOG	Neogen Corporation FY · 2026-05-31 Analysis WACC DCF	Other	$2.6B	46.9%
71	UG	UNITED-GUARDIAN, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$32M	46.9%
72	CHD	CHURCH & DWIGHT CO., INC. FY · 2025-12-31 Analysis WACC DCF	Other	$23.7B	44.7%
73	PLUR	PLURI INC. FY · 2026-06-30 Analysis WACC DCF	Other	$12M	44.6%
74	ECL	ECOLAB INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$79.7B	44.1%
75	CLX	CLOROX CO /DE/ TTM · 2026-03-31 Analysis WACC DCF	Other	$10.2B	43.8%
76	CF	CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$17.3B	42.5%
77	ICCC	ImmuCell Corporation FY · 2025-12-31 Analysis WACC DCF	Other	$87M	41.4%
78	PPG	PPG INDUSTRIES INC TTM · 2026-03-31 Analysis WACC DCF	Chemicals	$23.1B	41.4%
79	RPM	RPM International Inc. TTM · 2026-08-31 Analysis WACC DCF	Chemicals	$12.4B	41.1%
80	OPK	OPKO Health, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$1.0B	40.8%
81	PACK	RANPAK HOLDINGS CORP. TTM · 2026-06-30 Analysis WACC DCF	Paper Products	$310M	40.6%
82	EPC	EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$1.3B	40.4%
83	NGVT	INGEVITY CORPORATION FY · 2025-12-31 Analysis WACC DCF	Chemicals	$2.4B	39.5%
84	IFF	INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$21.7B	38.9%
85	KMB	KIMBERLY-CLARK CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Paper Products	$32.8B	36.8%
86	BCPC	Balchem Corporation TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$5.4B	36.3%
87	FMC	FMC CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$1.3B	35.3%
88	VTRS	VIATRIS INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$20.1B	34.9%
89	SXT	Sensient Technologies Corp TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$5.5B	34.6%
90	AXTA	AXALTA COATING SYSTEMS LTD. TTM · 2026-03-31 Analysis WACC DCF	Chemicals	$7.1B	34.2%
91	PAHC	Phibro Animal Health Corporation FY · 2026-06-30 Analysis WACC DCF	Other	$1.5B	33.8%
92	FUL	FULLER H B CO TTM · 2026-08-29 Analysis WACC DCF	Chemicals	$2.7B	32.3%
93	SMG	Scotts Miracle-Gro Co TTM · 2026-06-27 Analysis WACC DCF	Chemicals	$2.9B	32.3%
94	DSY	BIG TREE CLOUD HOLDINGS LIMITED FY · 2025-06-30 Analysis WACC DCF	Paper Products	$16M	32.2%
95	ROG	ROGERS CORP TTM · 2026-03-31 Analysis WACC DCF	Chemicals	$2.6B	32.2%
96	SOLS	Solstice Advanced Materials Inc. FY · 2025-12-31 Analysis WACC DCF	Chemicals	$9.6B	32.2%
97	NL	NLI HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$330M	32.1%
98	APD	AIR PRODUCTS AND CHEMICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$63.2B	32.1%
99	NEU	NEWMARKET CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Chemicals	$8.2B	31.5%
100	LFCR	LIFECORE BIOMEDICAL, INC. FY · 2025-05-25 Analysis WACC DCF	Other	$244M	31.3%